摘要
Catalase (CAT) is an important antioxidant enzyme that breaks down H2O2 into water and oxygen. Inhibitor-modulating CAT activity in cancer cells is emerging as a potential anticancer strategy. However, the discovery of CAT inhibitors towards the heme active center located at the bottom of long and narrow channel has made little progress. Therefore, targeting new binding site is of great importance for the development of efficient CAT inhibitors. Here, the first NADPH-binding site inhibitor of CAT, BT-Br, was designed and synthesized success-fully. The cocrystal structure of BT-Br-bound CAT complex was determined with a resolution of 2.2 angstrom (PDB ID:8HID), which showed clearly that BT-Br bound at the NADPH-binding site. Furthermore, BT-Br was demonstrated to induce ferroptosis in castration-resistant prostate cancer (CRPC) DU145 cells and eventually reduce CRPC tumors in vivo effectively. The work indicates that CAT has potential as a novel target for CRPC therapy based on ferroptosis inducing.
学科与关键词
- Catalase Inhibitors with Dual Pro-Oxidant Effect as New Therapeutic Agents in Castration-Resistant Prostate CancerChen, Yuan-Yuan; Liang, Hao-Qi; Liu, Meng-Ting; Huang, Wei; Yi, Peng-Fei; Yuan, Si-Qi; Mei, Long-Can; Hu, Ying-Hui; Cao, Ya-Ya; Hao, Ge-Fei; Zhang, Dan*; Yang, Guang-Fu*ADVANCED THERAPEUTICS, 2021, 4(3): 2000164.被引 1
- Inhibition of phosphoglycerate dehydrogenase induces ferroptosis and overcomes enzalutamide resistance in castration-resistant prostate cancer cellsWang, Jinxiang; Zeng, Leli; Wu, Nisha; Liang, Yanling; Jin, Jie; Fan, Mingming; Lai, Xiaoju; Chen, Zhe-Sheng; Pan, Yihang*; Zeng, Fangyin*; Deng, Fan*DRUG RESISTANCE UPDATES, 2023, 70: 100985.被引 2
- Self-catalyzed tumor ferroptosis based on ferrocene conjugated reactive oxygen species generation and a responsive polymerLi, Jisi; Zong, Qingyu; Liu, Ye; Xiao, Xuan; Zhou, Jielian; Zhao, Zhongyi; Yuan, Youyong*Chemical Communications, 2022, 58(20): 3294-3297.被引 6
